About: An overview of COVID-19

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: An overview of COVID-19 Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	An overview of COVID-19
Creator	Wang, Gang Shi, Yu Chen, Zhi Zheng, Min Zheng, Lin Yang, Cai, Xiao-Peng Deng, Jing-Wen Zhu, Hai-Hong
Source	Medline; PMC
abstract	Pneumonia caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection emerged in Wuhan City, Hubei Province, China in December 2019. By Feb. 11, 2020, the World Health Organization (WHO) officially named the disease resulting from infection with SARS-CoV-2 as coronavirus disease 2019 (COVID-19). COVID-19 represents a spectrum of clinical manifestations that typically include fever, dry cough, and fatigue, often with pulmonary involvement. SARS-CoV-2 is highly contagious and most individuals within the population at large are susceptible to infection. Wild animal hosts and infected patients are currently the main sources of disease which is transmitted via respiratory droplets and direct contact. Since the outbreak, the Chinese government and scientific community have acted rapidly to identify the causative agent and promptly shared the viral gene sequence, and have carried out measures to contain the epidemic. Meanwhile, recent research has revealed critical aspects of SARS-CoV-2 biology and disease pathogenesis; other studies have focused on epidemiology, clinical features, diagnosis, management, as well as drug and vaccine development. This review aims to summarize the latest research findings and to provide expert consensus. We will also share ongoing efforts and experience in China, which may provide insight on how to contain the epidemic and improve our understanding of this emerging infectious disease, together with updated guidance for prevention, control, and critical management of this pandemic.
has issue date	2020-05-08(xsd:dateTime)
bibo:doi	10.1631/jzus.b2000083
bibo:pmid	32425000
has license	no-cc
sha1sum (hex)	89c5b4dfd722256dcf0fa1a534d6ab40f945df3c
schema:url	https://doi.org/10.1631/jzus.b2000083
resource representing a document's title	An overview of COVID-19
has PubMed Central identifier	PMC7205601
has PubMed identifier	32425000
schema:publication	J Zhejiang Univ Sci B
resource representing a document's body	covid:89c5b4dfd722256dcf0fa1a534d6ab40f945df3c#body_text
is schema:about of	named entity 'epidemic' named entity 'COVID-19' named entity 'control' named entity 'prevention' named entity 'Since' named entity 'pulmonary' named entity 'measures' named entity 'MAIN' named entity 'SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2' named entity 'CITY' named entity 'STUDIES' named entity 'PATHOGENESIS' named entity 'LARGE' named entity 'SCIENTIFIC' named entity 'CARRIED' named entity 'Hubei Province' named entity 'management' named entity 'fever' named entity 'carried' named entity 'Wuhan' named entity 'caused' named entity 'epidemiology' named entity 'infection' named entity 'coronavirus disease 2019' named entity 'COVID-19' named entity 'China' named entity 'epidemic' named entity 'epidemiology' named entity 'SARS-CoV-2' named entity 'COVID' named entity 'highly contagious' named entity 'fever' named entity 'clinical features' named entity 'pathogenesis' named entity 'WHO' named entity 'infection' named entity 'vaccine' named entity 'SARS-CoV-2' named entity 'China' named entity 'COVID-19' named entity 'pathogenesis' named entity 'protein' named entity 'nucleocapsid' named entity 'host immune responses' named entity 'bronchus' named entity 'cathepsin' named entity 'SARS-CoV-2' named entity 'COVID' named entity 'IFN-α' named entity 'CET' named entity 'positive-sense, single-stranded' named entity 'virus infections' named entity 'Guangzhou' named entity 'mRNA' named entity 'COVID' named entity 'virus' named entity 'cell surface receptor' named entity 'membrane fusion' named entity 'nucleocapsid' named entity 'ORFs' named entity 'receptor' named entity 'animal models' named entity 'non-invasive ventilation' named entity 'COVID-19' named entity 'immunogen' named entity 'nucleic acid' named entity 'nucleic acid test' named entity 'glucocorticoid' named entity 'SARS-CoV-2' named entity 'proteases' named entity 'critically ill patients' named entity 'receptor' named entity 'lung'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software